ArticleBiosensors2026
A Multifrequency Millimeter-Wave CMOS Sensor for Non-Invasive Continuous Glucose Monitoring Using UMC 0.18 μm Technology.
Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes is a major worldwide health concern, which emphasizes the critical need for precise and continuous glucose monitoring devices. This paper introduces a novel, non-invasive method for continuous blood glucose monitoring using on-chip multi-arm sensors designed as earbuds by using UMC 0.18 μm technology. The proposed sensor uses the dielectric characteristics of the earbud to detect variations in glucose levels while operating at various resonant frequencies, including 32, 42, 64, and 94 GHz. The sensitivity of the proposed method was evaluated using a reflection coefficient criterion of ∣S11∣≤-6 dB, confirming its ability to achieve accurate detection when implemented within an earbud device. A 3D electromagnetic high-frequency structure simulator (HFSS) is used to validate the simulation. Only |S
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.